Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipiodol Embolization for Knee Osteoarthritis
NCT04733092Phase 1Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ethiodized oil in osteoarthritis (OA), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Serious Adverse Events at 1 month. Started Mar 2021; status: completed.
02
Drugs
ethiodized oil
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04733092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04733092.